---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-045512"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2023-12-20T23:59:59+00:00"
generated_at: "2026-06-07T09:46:34.381299+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# InspireMD receives U.S. patent for SwitchGuard NPS; IDE submission planned for 2024

## Summary
- U.S. Patent No. 11,844,893 issued for 'Shunts with Blood Flow Indicators' covering SwitchGuard NPS.
- SwitchGuard NPS designed to reverse blood flow and filter embolic debris during carotid stenting.
- Company expects to submit IDE to FDA in 2024 to initiate clinical trial for SwitchGuard NPS with CGuard Prime.
- CMS expanded coverage for carotid artery stenting to asymptomatic and standard risk patients in October 2023.

## SEC filing metadata
- accession: 0001493152-23-045512
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2023-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315223045512/0001493152-23-045512-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315223045512/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-045512
- JSON: https://secwatch.observer/filing/0001493152-23-045512.json
- Plain text: https://secwatch.observer/filing/0001493152-23-045512.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.